255 related articles for article (PubMed ID: 10100758)
61. 9p21 index as estimated by dual-color fluorescence in situ hybridization is useful to predict urothelial carcinoma recurrence in bladder washing cytology.
Kawauchi S; Sakai H; Ikemoto K; Eguchi S; Nakao M; Takihara H; Shimabukuro T; Furuya T; Oga A; Matsuyama H; Takahashi M; Sasaki K
Hum Pathol; 2009 Dec; 40(12):1783-9. PubMed ID: 19733894
[TBL] [Abstract][Full Text] [Related]
62. Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence.
Friedrich MG; Blind C; Milde-Langosch K; Erbersdobler A; Conrad S; Löning T; Hammerer P; Huland H
Eur Urol; 2001 Nov; 40(5):518-24. PubMed ID: 11752859
[TBL] [Abstract][Full Text] [Related]
63. Loss of heterozygosity in laryngeal cancer.
Rogowski M; Walenczak I; Pepiński W; Skawrońska M; Sieśkiewicz A; Klatka J
Rocz Akad Med Bialymst; 2004; 49():262-4. PubMed ID: 15631354
[TBL] [Abstract][Full Text] [Related]
64. Molecular genetic alterations in superficial and locally advanced human bladder cancer.
Presti JC; Reuter VE; Galan T; Fair WR; Cordon-Cardo C
Cancer Res; 1991 Oct; 51(19):5405-9. PubMed ID: 1680549
[TBL] [Abstract][Full Text] [Related]
65. Role of chromosome 9 in human bladder cancer.
Miyao N; Tsai YC; Lerner SP; Olumi AF; Spruck CH; Gonzalez-Zulueta M; Nichols PW; Skinner DG; Jones PA
Cancer Res; 1993 Sep; 53(17):4066-70. PubMed ID: 8358736
[TBL] [Abstract][Full Text] [Related]
66. Accumulated allelic losses in the development of invasive urothelial cancer.
Habuchi T; Ogawa O; Kakehi Y; Ogura K; Koshiba M; Hamazaki S; Takahashi R; Sugiyama T; Yoshida O
Int J Cancer; 1993 Feb; 53(4):579-84. PubMed ID: 8094713
[TBL] [Abstract][Full Text] [Related]
67. Noninvasive detection of alterations in chromosome numbers in urinary bladder cancer cells, using fluorescence in situ hybridization.
Okamura T; Umemoto Y; Yasui T; Saiki S; Kuroda H; Kotoh S; Kamizaki H
Int J Clin Oncol; 2004 Oct; 9(5):373-7. PubMed ID: 15549587
[TBL] [Abstract][Full Text] [Related]
68. Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma.
Cheng L; Jones TD; McCarthy RP; Eble JN; Wang M; MacLennan GT; Lopez-Beltran A; Yang XJ; Koch MO; Zhang S; Pan CX; Baldridge LA
Am J Pathol; 2005 May; 166(5):1533-9. PubMed ID: 15855652
[TBL] [Abstract][Full Text] [Related]
69. Numerical aberrations of chromosome 8 and allelic loss at 8p in non-muscle-invasive urothelial carcinomas of the urinary bladder.
Erbersdobler A; Kaiser H; Friedrich MG; Henke RP
Eur Urol; 2000 Nov; 38(5):590-6. PubMed ID: 11096241
[TBL] [Abstract][Full Text] [Related]
70. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas.
Yamaguchi T; Toguchida J; Wadayama B; Kanoe H; Nakayama T; Ishizaki K; Ikenaga M; Kotoura Y; Sasaki MS
Anticancer Res; 1996; 16(4A):2009-15. PubMed ID: 8712735
[TBL] [Abstract][Full Text] [Related]
71. Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis.
Lüttges J; Galehdari H; Bröcker V; Schwarte-Waldhoff I; Henne-Bruns D; Klöppel G; Schmiegel W; Hahn SA
Am J Pathol; 2001 May; 158(5):1677-83. PubMed ID: 11337365
[TBL] [Abstract][Full Text] [Related]
72. Superimposed histologic and genetic mapping of chromosome 17 alterations in human urinary bladder neoplasia.
Chaturvedi V; Li L; Hodges S; Johnston D; Ro JY; Logothetis C; von Eschenbach AC; Batsakis JG; Czerniak B
Oncogene; 1997 May; 14(17):2059-70. PubMed ID: 9160886
[TBL] [Abstract][Full Text] [Related]
73. Detection of c-erbB-2 amplification in transitional cell bladder carcinoma using competitive PCR technique.
Orlando C; Sestini R; Vona G; Pinzani P; Bianchi S; Giacca M; Pazzagli M; Selli C
J Urol; 1996 Dec; 156(6):2089-93. PubMed ID: 8911396
[TBL] [Abstract][Full Text] [Related]
74. The value of DNA cytometry in transitional cell carcinoma of the urinary bladder.
Nenning H; Rassler J; Minh DH; Stolzenburg JU
Gen Diagn Pathol; 1997 Dec; 143(4):231-6. PubMed ID: 9489956
[TBL] [Abstract][Full Text] [Related]
75. Two molecular pathways to transitional cell carcinoma of the bladder.
Spruck CH; Ohneseit PF; Gonzalez-Zulueta M; Esrig D; Miyao N; Tsai YC; Lerner SP; Schmütte C; Yang AS; Cote R
Cancer Res; 1994 Feb; 54(3):784-8. PubMed ID: 8306342
[TBL] [Abstract][Full Text] [Related]
76. Microsatellite instability in bladder cancer.
Gonzalez-Zulueta M; Ruppert JM; Tokino K; Tsai YC; Spruck CH; Miyao N; Nichols PW; Hermann GG; Horn T; Steven K
Cancer Res; 1993 Dec; 53(23):5620-3. PubMed ID: 8242615
[TBL] [Abstract][Full Text] [Related]
77. Papillary urothelial hyperplasia is a clonal precursor to papillary transitional cell bladder cancer.
Chow NH; Cairns P; Eisenberger CF; Schoenberg MP; Taylor DC; Epstein JI; Sidransky D
Int J Cancer; 2000 Nov; 89(6):514-8. PubMed ID: 11102896
[TBL] [Abstract][Full Text] [Related]
78. Genetic mechanisms in esophageal carcinogenesis: frequent deletion of 3p and 17p in premalignant lesions.
Shimada M; Yanagisawa A; Kato Y; Inoue M; Shiozaki H; Monden M; Nakamura Y
Genes Chromosomes Cancer; 1996 Mar; 15(3):165-9. PubMed ID: 8721680
[TBL] [Abstract][Full Text] [Related]
79. Allelic imbalance at 1p36 may predict prognosis of chemoradiation therapy for bladder preservation in patients with invasive bladder cancer.
Matsumoto H; Matsuyama H; Fukunaga K; Yoshihiro S; Wada T; Naito K
Br J Cancer; 2004 Sep; 91(6):1025-31. PubMed ID: 15292937
[TBL] [Abstract][Full Text] [Related]
80. Cluster of allele losses within a 2.5 cM region of chromosome 10 in high-grade invasive bladder cancer.
Kagan J; Liu J; Stein JD; Wagner SS; Babkowski R; Grossman BH; Katz RL
Oncogene; 1998 Feb; 16(7):909-13. PubMed ID: 9484782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]